FDA NDC Directory · JSON-LD · Markdown
NDC 67184-1001 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION
| Labeler / Manufacturer | Qilu Pharmaceutical Co., Ltd. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA203661 |
| Dosage form / route | INJECTION, POWDER, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS |
| Active ingredients | CEFAZOLIN SODIUM (1 g/1) |
| Marketing started | 20151228 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).